Juvederm VOLLURE XC ™ is the first and only Hyaluronic acid dermal filler FDA approved for the correction of moderate to severe wrinkles and folds, such as nasolabial folds.

Juvederm VOLLURE XC™ lasts up to 18 months and is formulated with unique Vycross® technology, which blends different molecular weights of Hyaluronic acid, contributing to the gel’s duration.

The first product featuring Vycross® technology, Juvederm VOLUMA XC, was FDA-approved to increase volume lost due to aging in the cheek area, followed by Juvederm VOLBELLA XC, FDA-approved for lip augmentation and correction of perioral wrinkles (smoker’s lines).

Juvederm VOLLURE XC is specifically tailored with a balance of gel firmness and low cohesivity, yielding a versatile formulation that adds subtle volume for the correction of moderate to severe facial wrinkles and folds. Juvederm VOLLURE was first approved in Europe as Juvederm VOLIFT® in 2013.

The most common side effects seen in the clinical studies were temporary injection site responses such as swelling, tenderness, bruising, firmness lumps/bumps, redness, pain, and itching. Most side effects are mild and lasted 7 days or less.

Do not use this product if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to Lidocaine. As with all skin injection procedures, there is a risk of infection.

  • The safety of Juvederm VOLLURE for use during pregnancy, while breastfeeding, or in patients under 22 years has not been studied
  • The safety and effectiveness of Juvederm VOLLURE in areas other than facial wrinkles and folds have not been established in clinical studies
  • Tell your doctor if you have a history of excessive scarring (e.g., hypertrophic scarring and keloid formations) or pigmentation disorders, as use of this product may result in additional scars or changes in pigmentation
  • Tell your doctor if you are using medications that can prolong bleeding, such as Aspirin, Ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site
  • Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within the first 24 hours following treatment
609 Plandome Rd. • Manhasset, NY 11030 • 718-357-2300
Happy Clients